Published in Cancer Res on April 15, 1991
Intraperitoneal therapy for peritoneal cancer. Future Oncol (2010) 1.25
Tumor-penetrating microparticles for intraperitoneal therapy of ovarian cancer. J Pharmacol Exp Ther (2008) 1.06
Use of etoposide in patients with organ dysfunction: pharmacokinetic and pharmacodynamic considerations. Cancer Chemother Pharmacol (1994) 0.83
Therapeutic strategies based on polymeric microparticles. J Biomed Biotechnol (2012) 0.83
Etoposide sensitizes CT26 colorectal adenocarcinoma to radiation therapy in BALB/c mice. World J Gastroenterol (2005) 0.75
A phase I and pharmacokinetic study of intraperitoneal carboplatin and etoposide. Br J Cancer (1993) 0.75
Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med (1994) 7.19
DTIC (NSC-45388) in malignant melanoma: a perspective. Cancer Treat Rep (1976) 2.59
The integration of chemotherapy into a combined modality approach for cancer treatment. VI. Pancreatic adenocarcinoma. Cancer Treat Rev (1975) 2.10
Transient electric dichroism of rod-like DNA molecules. Proc Natl Acad Sci U S A (1978) 2.05
Simultaneous multianalyte ELISA performed on a microarray platform. Clin Chem (2001) 1.89
Policy implications for implementing evidence-based practices. Psychiatr Serv (2001) 1.87
The amino acid sequence of bovine parathyroid hormone I. Hoppe Seylers Z Physiol Chem (1970) 1.75
Dependence of DNA helix flexibility on base composition. Nature (1983) 1.73
Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis. J Clin Oncol (1995) 1.67
The pulmonary toxicity of antineoplastic agents. Semin Oncol (1982) 1.65
Depletion of glutathione in normal and malignant human cells in vivo by buthionine sulfoximine: clinical and biochemical results. J Natl Cancer Inst (1992) 1.61
A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B. J Clin Oncol (1989) 1.56
Socioeconomic status and cancer survival. J Clin Oncol (1991) 1.48
Transmission of allosteric effects in DNA. Nature (1979) 1.44
How to contain generalized HIV epidemics? A plea for better evidence to displace speculation. Int J STD AIDS (2009) 1.42
Long-term survival results for patients with locally advanced, initially unresectable non-small cell lung cancer treated with aggressive concurrent chemoradiation. Cancer J Sci Am (2006) 1.38
Differential effects of omeprazole and pantoprazole on the pharmacodynamics and pharmacokinetics of clopidogrel in healthy subjects: randomized, placebo-controlled, crossover comparison studies. Clin Pharmacol Ther (2010) 1.36
A nuclear specific glycoprotein representative of a unique pattern of glycosylation. J Biol Chem (1987) 1.34
Interactions between human eosinophils and schistosomula of Schistosoma mansoni. II. The mechanism of irreversible eosinophil adherence. J Exp Med (1979) 1.34
Interaction of netropsin and distamycin with deoxyribonucleic acid: electric dichroism study. Biochemistry (1980) 1.30
Transient electric dichroism studies of the structure of the DNA complex with intercalated drugs. Biochemistry (1979) 1.29
Cost effective Internet access and video conferencing for a community cancer network. Proc Annu Symp Comput Appl Med Care (1995) 1.28
Structural changes of nucleosomes in low-salt concentrations. Biochemistry (1979) 1.23
Lateral diffusion in nuclear membranes. J Cell Biol (1985) 1.22
Purification and properties of phosphoglucomutase from Fleischmann's yeast. Eur J Biochem (1975) 1.16
Binding of bleomycin to DNA: intercalation of the bithiazole rings. Biochemistry (1979) 1.15
Transient electric dichroism studies of nucleosomal particles. Biochemistry (1978) 1.14
Phase I study of thiotepa in combination with the glutathione transferase inhibitor ethacrynic acid. Cancer Res (1991) 1.13
The clinical effects of intensive, specific exercise on chronic low back pain: a controlled study of 895 consecutive patients with 1-year follow up. Orthopedics (1995) 1.11
Pharmacokinetics and pharmacodynamics of dapagliflozin, a novel selective inhibitor of sodium-glucose co-transporter type 2, in Japanese subjects without and with type 2 diabetes mellitus. Diabetes Obes Metab (2011) 1.10
The adherence of human neutrophils and eosinophils to schistosomula: evidence for membrane fusion between cells and parasites. J Cell Biol (1980) 1.10
DNA motions in the nucleosome core particle. Proc Natl Acad Sci U S A (1982) 1.10
A microchip for quantitative detection of molecules utilizing luminescent and radioisotope reporter groups. Biotechniques (1994) 1.09
A review of chemotherapy in gastric cancer. Cancer (1974) 1.09
Partial and complete detachment of neutrophils and eosinophils from schistosomula: evidence for the establishment of continuity between a fused and normal parasite membrane. J Cell Biol (1980) 1.07
Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer. J Clin Oncol (1996) 1.07
Adolescent sexual aggression: risk and protective factors. Pediatrics (1997) 1.07
The implementation of telemedicine within a community cancer network. J Am Med Inform Assoc (1997) 1.07
Physical studies of nucleosome assemble. Biochemistry (1978) 1.06
Molecular motion of DNA as measured by triplet anisotropy decay. Proc Natl Acad Sci U S A (1982) 1.05
Role of single-breath carbon monoxide-diffusing capacity in monitoring the pulmonary effects of bleomycin in germ cell tumor patients. Cancer Res (1979) 1.05
Lack of pharmacokinetic interaction between dapagliflozin, a novel sodium-glucose transporter 2 inhibitor, and metformin, pioglitazone, glimepiride or sitagliptin in healthy subjects. Diabetes Obes Metab (2011) 1.03
Phase I and pharmacokinetic study of ormaplatin (tetraplatin, NSC 363812) administered on a day 1 and day 8 schedule. Cancer Res (1994) 1.03
Immune evasion by Schistosoma mansoni: loss of susceptibility to antibody or complement-dependent eosinophil attack by schistosomula cultured in medium free of macromolecules. Parasitology (1981) 1.03
The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groups. Bioorg Med Chem Lett (2001) 1.02
Phase I evaluation of an anti-breast carcinoma monoclonal antibody 260F9-recombinant ricin A chain immunoconjugate. Cancer Res (1989) 1.01
Phase I/pharmacokinetic study of topotecan by 24-hour continuous infusion weekly. Cancer Res (1994) 1.01
Interactions between human eosinophils and schistosomula of Schistosoma mansoni. I. Stable and irreversible antibody-dependent adherence. J Immunol (1980) 0.99
Adenocarcinoma arising in extragonadal endometriosis: an immunohistochemical study. Cancer (1998) 0.99
DNA microarrays based on noncovalent oligonucleotide attachment and hybridization in two dimensions. Anal Biochem (2001) 0.98
Integration of chemotherapy into combined modality therapy of solid tumors. IV. Malignant melanoma. Cancer Treat Rev (1974) 0.98
Noncorrelation of the expression of the c-myc oncogene in colorectal carcinoma with recurrence of disease or patient survival. Cancer Res (1988) 0.96
Enzymatic conjugation of chlorambucil with glutathione by human glutathione S-transferases and inhibition by ethacrynic acid. Biochem Pharmacol (1991) 0.95
Hexamethylmelamine and low or moderate dose cisplatin with or without pyridoxine for treatment of advanced ovarian carcinoma: a study of the Eastern Cooperative Oncology Group. Cancer Invest (1992) 0.95
Electric dichroism studies of the size and shape of nucleosomal particles. Cold Spring Harb Symp Quant Biol (1978) 0.94
Copper(II).bleomycin, iron(III).bleomycin, and copper(II).phleomycin: comparative study of deoxyribonucleic acid binding. Biochemistry (1981) 0.93
Evaluation of glutathione-sensitive fluorescent dyes in cortical culture. Glia (2000) 0.93
Unfolding of nucleosomes by ethidium binding. Biochemistry (1980) 0.93
Small cell carcinoma of the lung. Cancer Treat Rev (1982) 0.93
Phase II trial of 6-diazo-5-oxo-L-norleucine versus aclacinomycin-A in advanced sarcomas and mesotheliomas. Invest New Drugs (1990) 0.92
Detection of DNA gains and losses in primary endometrial carcinomas by comparative genomic hybridization. Genes Chromosomes Cancer (1997) 0.91
The spontaneous and glutathione S-transferase-mediated reaction of chlorambucil with glutathione. Cancer Commun (1990) 0.91
Does irehdiamine kink DNA? Proc Natl Acad Sci U S A (1978) 0.91
Site-specific derivatives of wheat germ calmodulin. Interactions with troponin and sarcoplasmic reticulum. J Biol Chem (1988) 0.91
Design and validation of a multiplex specific primer-directed polymerase chain reaction assay for killer-cell immunoglobulin-like receptor genetic profiling. Tissue Antigens (2011) 0.90
Nearly instantaneous, cation-independent, high selectivity nucleic acid hybridization to DNA microarrays. Biochem Biophys Res Commun (2001) 0.90
Oligonucleotides form a duplex with non-helical properties on a positively charged surface. Nucleic Acids Res (2001) 0.90
Phase II study of biochemical modulation of fluorouracil by low-dose PALA in patients with colorectal cancer. J Clin Oncol (1990) 0.90
Effect of a high-fat meal on the pharmacokinetics of dapagliflozin, a selective SGLT2 inhibitor, in healthy subjects. Diabetes Obes Metab (2011) 0.89
Multiple deprivation and excess winter deaths in Scotland. J R Soc Promot Health (2005) 0.88
Phase II trial of extended indications for resection is small cell carcinoma of the lung. J Thorac Cardiovasc Surg (1982) 0.88
Evidence from cultured rat cortical neurons of differences in the mechanism of ischemic preconditioning of brain and heart. Brain Res (1999) 0.88
A comprehensive multidisciplinary ambulatory clerkship. Acad Med (1996) 0.88
Characterization of glutathione S-transferase expression in lymphocytes from chronic lymphocytic leukemia patients. Cancer Res (1990) 0.88
Molecular alterations to human chromosome 3p loci in neuroendocrine lung tumors. Cancer (1998) 0.88
Peritoneal washing cytology. Uses and diagnostic criteria in gynecologic neoplasms. Acta Cytol (1984) 0.87
Structure of DNA within three isometric bacteriophages. Cell (1979) 0.86
Cyanide intoxication among silver-reclaiming workers. JAMA (1985) 0.86
Hyperperfusion on perfusion computed tomography following revascularization for acute stroke. Acta Radiol (2005) 0.86
Primary, localized vulvar B-cell lymphoma expressing CD44 variant 6 but not cadherins. A case report. J Reprod Med (2000) 0.85
Pharmakokinetics and bioavailability study of ethacrynic acid as a modulator of drug resistance in patients with cancer. J Pharmacol Exp Ther (1994) 0.85
A dose-escalation study of the safety, tolerability, and pharmacokinetics of intravenous gatifloxacin in healthy adult men. Pharmacotherapy (2000) 0.84
Impaired interleukin regulation of the phytohemagglutinin response in Hodgkin's disease. Clin Immunol Immunopathol (1985) 0.84
Renal cell carcinoma: treatment with recombinant interleukin-2 plus beta-interferon. J Clin Oncol (1990) 0.83
Regulation of phosphatidylcholine synthesis in fetal type II cells by CTP:phosphocholine cytidylyltransferase. Am J Physiol (1993) 0.83
Abnormalities in water homeostasis in small cell anaplastic lung cancer. Cancer (1980) 0.83
Gastric cancer: current status of treatment. J Natl Cancer Inst (1977) 0.83
Bioavailability and pharmacokinetics of etoposide (VP-16). Semin Oncol (1985) 0.82
Relatives' views of health care in the last year of life. Int J Palliat Nurs (2001) 0.82
A phase I and clinical pharmacology study of intravenously administered carminomycin in cancer patients in the United States. Cancer Res (1982) 0.82
The in vitro insertion of monoamine oxidase B into mitochondrial outer membranes. FEBS Lett (1988) 0.82
An equilibrium between distorted and undistorted DNA in the adult chicken beta A-globin gene. J Biol Chem (1985) 0.82
Renal tumors in rats given trisodium nitrilotriacetic acid in drinking water for 2 years. J Natl Cancer Inst (1981) 0.82
Cross-tolerance to otherwise lethal N-methyl-D-aspartate and oxygen-glucose deprivation in preconditioned cortical cultures. Neuroscience (2001) 0.82
Increased levels of glutathione S-transferase pi transcript as a mechanism of resistance to ethacrynic acid. Biochem J (1992) 0.82
Divergent dose-related effects of gamma-interferon therapy on in vitro antibody-dependent cellular and nonspecific cytotoxicity by human peripheral blood monocytes. Cancer Res (1988) 0.82